IL36G and inflammatory bowel disease: Although significant progress has been made towards managing IBD, understanding the role of IL-36 cytokine family in IBD pathogenesis is crucial since the antagonist IL-36γ is elevated in human IBD and experimental colitis, as well as other inflammatory diseases.